• amedes Group ("amedes") is a leading provider of medical diagnostic services, with 35 laboratories and 27 practices across Germany and Belgium. The business offers interdisciplinary and medical-diagnostic services for patients, medical practitioners, clinics and other institutions
  • DC Advisory ("DC") was engaged by Antin Infrastructure Partners ("Antin IP") to provide M&A and debt advice on the acquisition of amedes
  • The transaction was executed on a bilateral, non-competitive basis. The DC team ran a focused M&A and debt process, assisting Antin IP in conducting extensive due diligence, commercial negotiations, financial modelling and legal drafting, whilst also targeting key financing providers to arrange an infrastructure-style debt financing
  • DC ensured all internal workstreams were successfully completed within a challenging timeframe, while ensuring full confidentiality of the process
  • A robust infrastructure-style financing package, fully underwritten by Goldman Sachs, Nomura and CACIB, was delivered in line with Antin's requirements for shareholder distributions whilst minimising cash sweeps, margins and fees; and featuring a large capex facility to support the continued growth of the business
  • On 10 July 2015, General Atlantic and Antin IP announced the signing of the agreement relating to the sale of the amedes Group to Antin IP. The acquisition price was not disclosed